Cardiovascular related uses of IL-1β antibodies and binding fragments thereof
US10611832B2 · kind B2 · utility
0Cited by
2References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2017 |
| Grant date | Apr 7, 2020 |
| Priority date | — |
| Expiry date | Jul 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods for the reduction, prevention or treatment of cardiovascular events and/or cardiovascular diseases, including acute cardiovascular disease or chronic cardiovascular disease using anti-IL-1β binding molecules (e.g., IL-1β binding antibodies and fragments thereof). The present disclosure also relates to methods for prevention or treatment of cardiovascular events and/or cardiovascular diseases, including by reducing a cardiovascular event or disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.